WATCH NOW

First Name*

Last Name*

Email *

Company *

Job Title*

Company Type *

Yes, I'd like to sign up for the BioPharma Dive newsletter. You can unsubscribe at any time.

By completing this form, you accept the Terms of Use and Privacy Policy. You also agree to having your information shared with our sponsor, Alimentiv.*

ON DEMAND WEBINAR
Duration: 1 hour

Our expert panel will discuss inflammatory bowel disease and NASH, two therapeutic areas that histopathology uses to determine eligibility and/or primary outcome measures. Our four experts will provide presentations on topics including:

Histopathology as a treatment target in IBD: Aspiration or Reality?
Measuring histopathology in IBD trials
Histopathology as a treatment target in NASH trials
Measuring histopathology in NASH trials

SPEAKERS

David Rubin, MD

Chief, Section of Gastroenterology,
Hepatology, and Nutrition
University of Chicago, IL

Rish Pai, MD, PhD

Histopathologist
Mayo Clinic, AZ

Stephen Harrison, MD

Hepatologist and Clinical Trialist
San Antonio, TX

Mark Valasek, MD

Associate Professor, Pathology
UCSD, CA

Implementation of Histopathology in Gastrointestinal Clinical Trials:

Accelerate Time to Market for GI Clinical Trials

WATCH NOW

SPEAKERS